$VCNX VACCINEX, INC. Insider Trading
Get free email notifications about insider trading in VACCINEX, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VACCINEX, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in VACCINEX, INC. for free.
IRS Number: 161603202
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: VCNX
Company Address: 1895 MOUNT HOPE AVE ROCHESTER 14620
Phone number: 585-271-2700
Former name: VACCINEX INC, date of change: 2002-11-14
Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The firm focuses on the development of Pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma, and Huntington’s disease. Its product pipeline includes the SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in 1997 and is headquartered in Rochester, NY.
VACCINEX, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | VCNX | VACCINEX, INC. | Goater Jeff | Director | Option Exercise | A | 2.15 | 28,586 | 61,460 | 28,586 | |
| May 12 2021 | VCNX | VACCINEX, INC. | MANIAN BALA S | Director | Option Exercise | A | 2.15 | 28,586 | 61,460 | 28,586 | |
| May 12 2021 | VCNX | VACCINEX, INC. | Yanni Barbara | Director | Option Exercise | A | 2.15 | 28,586 | 61,460 | 28,586 | |
| May 12 2021 | VCNX | VACCINEX, INC. | Stecyk Chrystyna Bedrij | Director | Option Exercise | A | 2.15 | 28,586 | 61,460 | 28,586 | |
| May 12 2021 | VCNX | VACCINEX, INC. | Van Strydonck, Gerald E. | Director | Option Exercise | A | 2.15 | 28,586 | 61,460 | 28,586 | |
| May 12 2021 | VCNX | VACCINEX, INC. | Frieberg Jacob B. | Director | Option Exercise | A | 2.15 | 28,586 | 61,460 | 28,586 | |
| Apr 02 2021 | VCNX | VACCINEX, INC. | Royer Scott E. | Chief Financial Off ... | Option Exercise | A | 2.93 | 6,000 | 17,580 | 6,000 | |
| Apr 02 2021 | VCNX | VACCINEX, INC. | Zauderer Maurice | President and CEO | Option Exercise | A | 2.93 | 14,000 | 41,020 | 14,000 | |
| Apr 02 2021 | VCNX | VACCINEX, INC. | Leonard John E. | SVP, Development | Option Exercise | A | 2.93 | 8,000 | 23,440 | 8,000 | |
| Apr 02 2021 | VCNX | VACCINEX, INC. | Smith Ernest S. | SVP, Research & CSO | Option Exercise | A | 2.93 | 10,000 | 29,300 | 10,000 | |
| Apr 01 2021 | VCNX | VACCINEX, INC. | Frieberg Jacob B. | Director | Option Exercise | A | 2.98 | 4,535 | 13,514 | 4,535 | |
| Jan 04 2021 | VCNX | VACCINEX, INC. | Frieberg Jacob B. | Director | Option Exercise | A | 2.07 | 6,545 | 13,548 | 6,545 | |
| Oct 01 2020 | VCNX | VACCINEX, INC. | Frieberg Jacob B. | Director | Option Exercise | A | 1.78 | 7,626 | 13,574 | 7,626 | |
| Sep 03 2020 | VCNX | VACCINEX, INC. | Royer Scott E. | Chief Financial Off ... | Option Exercise | M | 3.90 | 500 | 1,950 | 1,500 | |
| Sep 03 2020 | VCNX | VACCINEX, INC. | Royer Scott E. | Chief Financial Off ... | Buy | M | 3.90 | 500 | 1,950 | 4,499 | 4 K to 4.5 K (+12.50 %) |